Inhaled therapies in patients with moderate COPD in clinical practice: current thinking

Ariel, Amnon; Altraja, Alan; Belevskiy, Andrey; Boros, Piotr; Danila, Edvardas; Flezar, Matjaz; Koblizek, Vladimir; Fridlender, Zvi Gregorio; Kostov, Kosta; Krams, Alvils; Milenkovic, Branislava; Somfay, Attila; Tkacova, Ruzena; Tudorić, Neven; Ulmeanu, Ruxandra; Valipour, Arschang

doi:10.2147/COPD.S145573

Scientific paper - Original scientific paper

Inhaled therapies in patients with moderate COPD in clinical practice: current thinking

International Journal of Chronic Obstructive Pulmonary Disease, 13 (2017); 45-56. https://doi.org/10.2147/COPD.S145573

Ariel, Amnon; Altraja, Alan; Belevskiy, Andrey; Boros, Piotr; Danila, Edvardas; Flezar, Matjaz; Koblizek, Vladimir; Fridlender, Zvi Gregorio; Kostov, Kosta; Krams, Alvils; Milenkovic, Branislava; Somfay, Attila; Tkacova, Ruzena; Tudorić, Neven; Ulmeanu, Ruxandra; Valipour, Arschang More authors...

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

APA 6th Edition

Ariel, A., Altraja, A., Belevskiy, A., Boros, P., Danila, E., Flezar, M. ... Valipour, A. (2017). Inhaled therapies in patients with moderate COPD in clinical practice: current thinking. International Journal of Chronic Obstructive Pulmonary Disease, 13., 45-56. doi: 10.2147/COPD.S145573

MLA 8th Edition

Ariel, Amnon, et al. "Inhaled therapies in patients with moderate COPD in clinical practice: current thinking." International Journal of Chronic Obstructive Pulmonary Disease, vol. 13, 2017, pp. 45-56. https://doi.org/10.2147/COPD.S145573

Chicago 17th Edition

Ariel, Amnon, Alan Altraja, Andrey Belevskiy, Piotr Boros, Edvardas Danila, Matjaz Flezar, Vladimir Koblizek, et al. "Inhaled therapies in patients with moderate COPD in clinical practice: current thinking." International Journal of Chronic Obstructive Pulmonary Disease 13 (2017): 45-56. https://doi.org/10.2147/COPD.S145573

Harvard

Ariel, A., et al. (2017) 'Inhaled therapies in patients with moderate COPD in clinical practice: current thinking', International Journal of Chronic Obstructive Pulmonary Disease, 13, pp. 45-56. doi: 10.2147/COPD.S145573

Vancouver

Ariel A, Altraja A, Belevskiy A, Boros P, Danila E, Flezar M, and sur.. Inhaled therapies in patients with moderate COPD in clinical practice: current thinking. International Journal of Chronic Obstructive Pulmonary Disease [Internet]. 2017 December 21 [cited 2024 May 02];13:45-56. doi: 10.2147/COPD.S145573

IEEE

A. Ariel, et al., "Inhaled therapies in patients with moderate COPD in clinical practice: current thinking", International Journal of Chronic Obstructive Pulmonary Disease, vol. 13, pp. 45-56, December 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:888485. [Accessed: 02 May 2024]

Cite this item: https://urn.nsk.hr/urn:nbn:hr:105:888485

Metadata

Title (english)	Inhaled therapies in patients with moderate COPD in clinical practice: current thinking
Author	Amnon Ariel
Author	Alan Altraja
Author	Andrey Belevskiy
Author	Piotr Boros
Author	Edvardas Danila
Author	Matjaz Flezar
Author	Vladimir Koblizek
Author	Zvi Gregorio Fridlender
Author	Kosta Kostov
Author	Alvils Krams
Author	Branislava Milenkovic
Author	Attila Somfay
Author	Ruzena Tkacova
Author	Neven Tudorić
Author	Ruxandra Ulmeanu
Author	Arschang Valipour
Author's institution	University of Zagreb School of Medicine
Scientific / art field, discipline and subdiscipline	BIOMEDICINE AND HEALTHCARE Clinical Medical Sciences
Abstract (english)	COPD is a complex, heterogeneous condition. Even in the early clinical stages, COPD carries a significant burden, with breathlessness frequently leading to a reduction in exercise capacity and changes that correlate with long-term patient outcomes and mortality. Implementation of an effective management strategy is required to reduce symptoms, preserve lung function, quality of life, and exercise capacity, and prevent exacerbations. However, current clinical practice frequently differs from published guidelines on the management of COPD. This review focuses on the current scientific evidence and expert opinion on the management of moderate COPD: the symptoms arising from moderate airflow obstruction and the burden these symptoms impose, how physical activity can improve disease outcomes, the benefits of dual bronchodilation in COPD, and the limited evidence for the benefits of inhaled corticosteroids in this disease. We emphasize the importance of maximizing bronchodilation in COPD with inhaled dual-bronchodilator treatment, enhancing patient-related outcomes, and enabling the withdrawal of inhaled corticosteroids in COPD in well-defined patient groups.
Keywords (english)
Language	english
Publication type	Scientific paper - Original scientific paper
Publication status	Published
Peer review	Peer review
Publication version	Published version
Journal title	International Journal of Chronic Obstructive Pulmonary Disease
Numbering	vol. 13, pp. 45-56
p-ISSN	1178-2005
DOI	https://doi.org/10.2147/COPD.S145573
URN:NBN	urn:nbn:hr:105:888485
Publication	2017-12-21
Document URL	https://doi.org/10.2147/COPD.S145573
Type of resource	Text
Access conditions	Open access
Terms of use
Created on	2024-03-28 10:09:58

Search form